Health - Each of the Health Centers is a gateway to one of our information banks devoted to one particular health topic or a group of related topics. You can access the latest health news, recent reports, reviews or in-depth articles with just a couple of clicks.
January 8, 2009 go to professionals site
   [Suggest to a Friend]
[Subscribe to Newsletter]







  RSS

Choose Font Size
Normal
Large
Extra Large

Digestive Problems Center

[ Health Centers >  Digestive Problems >  RELATED NEWS ]

Aspirin's Action Against Colon Cancer

Robert W. Griffith, MD

Two large randomized studies done in UK provide what an editorialist calls "convincing evidence" that aspirin prevents colorectal cancer. Now the USA gets into the act with two more studies, recently published in the New England Journal of Medicine. The Nurses Health Study (121,700 women) and the Health Professionals Follow-up Study (51,500 men) provided the data.

Now for some simplified science. COX-2 is a cyclooxygenase enzyme produced in a number of tissues, often in response to inflammation. It's been thought, based on the effectiveness of different types of non-steroid anti-inflammatory drugs (and their side effects) that the COX-1 enzyme is specific for intestinal lining cells and COX-2 for pain and inflammation. This was the reason that COX-2 inhibitors, like Vioxx®, improve pain and inflammation without causing gastrointestinal side effects, whereas aspirin (a COX-1 and COX-2 inhibitor) helps pain and inflammation but also irritates the stomach and intestine lining. Why is this important for colon cancer?

The US studies estimated COX-2 levels (called 'expression') in cancer tissue taken from 636 colorectal cancers. Of these, two-thirds had moderate or strong COX-2 expression; the remainder was COX-2 negative. However, regular aspirin users had almost half the risk of COX-2 tumors, while they had the same risk for COX-2-negative tumors.

The practical conclusions from these studies are limited. At present there's no good way to determine which patients are likely to develop COX-2 tumors rather than non-COX-2 tumors, so the benefits of aspirin are a bit hit-and-miss. Of course, if someone has had a polyp removed and this is examined for COX-2 expression, there could be a much better reason for instituting regular aspirin therapy. And the very fact that reduced tumor frequency is tied to COX-2 in some fashion means there's a starting point for new drug development.

Source
HealthandAge Blog

Please take a moment to give us your comments. For questions about Health matters you may check our "Questions & Answers" Portal and Service.



Copyright © 2006. All rights reserved. [ Privacy Policy | Terms of Use | About Us | Site Map ]